Your browser doesn't support javascript.
loading
Tenascin-C expression in prostatic intraepithelial neoplasia (PIN): a marker of progression?
Xue, Y; Smedts, F; Latijnhouwers, M A; Ruijter, E T; Aalders, T W; de la Rosette, J J; Debruyne, F M; Schalken, J A.
Affiliation
  • Xue Y; Department of Urology, University Hospital Nijmegen, The Netherlands.
Anticancer Res ; 18(4A): 2679-84, 1998.
Article in En | MEDLINE | ID: mdl-9703928
ABSTRACT

BACKGROUND:

Tenascin (tenascin-C) has been suggested to be associated with active epithelial-stromal interactions. We evaluated tenascin expression in tissue remodelling processes presumably associated with PIN and prostate carcinoma (PCa). MATERIALS AND

METHODS:

Tenascin immunoreactivity was evaluated in 38 PIN lesions (low-grade = 5, high-grade = 33) from 27 paraffin-embedded PCa specimens, and compared with expression in pre-existent (normal) prostate, benign prostatic hyperplasia (BPH), and PCa.

RESULTS:

Periepithelial stromal tenascin expression was low in low-grade PIN, and similar to normal glands and BPH, whereas expression in high-grade PIN was high and partly overlapped that of well-/moderately differentiated PCa. High-grade PCa usually expressed little, if any tenascin.

CONCLUSIONS:

The variable periglandular tenascin expression in high-grade PIN may reflect the biologic behaviour of this lesion, and may be indicative of variable levels of tissue remodelling. In well/moderately differentiated PCa tenascin expression levels may be an indicator of tumour progression.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Prostate / Prostatic Hyperplasia / Prostatic Neoplasms / Tenascin Type of study: Observational_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Anticancer Res Year: 1998 Document type: Article Affiliation country: Netherlands
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Prostate / Prostatic Hyperplasia / Prostatic Neoplasms / Tenascin Type of study: Observational_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Anticancer Res Year: 1998 Document type: Article Affiliation country: Netherlands